Cite
Bardor M, Loutelier-Bourhis C, Paccalet T, et al. Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures. Plant Biotechnol J. 2003;1(6):451-62doi: 10.1046/j.1467-7652.2003.00041.x.
Bardor, M., Loutelier-Bourhis, C., Paccalet, T., Cosette, P., Fitchette, A. C., Vézina, L. P., Trépanier, S., Dargis, M., Lemieux, R., Lange, C., Faye, L., & Lerouge, P. (2003). Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures. Plant biotechnology journal, 1(6), 451-62. https://doi.org/10.1046/j.1467-7652.2003.00041.x
Bardor, Muriel, et al. "Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures." Plant biotechnology journal vol. 1,6 (2003): 451-62. doi: https://doi.org/10.1046/j.1467-7652.2003.00041.x
Bardor M, Loutelier-Bourhis C, Paccalet T, Cosette P, Fitchette AC, Vézina LP, Trépanier S, Dargis M, Lemieux R, Lange C, Faye L, Lerouge P. Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures. Plant Biotechnol J. 2003 Nov;1(6):451-62. doi: 10.1046/j.1467-7652.2003.00041.x. PMID: 17134403.
Copy
Download .nbib